We have data on 311 companies that use Genome Analysis Toolkit. The companies using Genome Analysis Toolkit are most often found in United States and in the Higher Education industry. Genome Analysis Toolkit is most often used by companies with >10000 employees and >1000M dollars in revenue. Our data for Genome Analysis Toolkit usage goes back as far as 1 years and 5 months.
|Ambry Genetics Corp.||ambrygen.com||United States||100M-200M||500-1000|
|University of California-Merced||ucmerced.edu||United States||200M-1000M||1000-5000|
|AbbVie Inc.||abbvie.com||United States||>1000M||>10000|
|University of Glasgow||gla.ac.uk||United Kingdom||>1000M||>10000|
|Federal Deposit Insurance Corporation||fdic.gov||United States||>1000M||>10000|
We use the best scanning techniques combined with advanced data science to monitor the market share of over 5,000 technology products, including Healthcare. In the Healthcare category, Genome Analysis Toolkit has a market share of about 0.3%. Other major and competing products in this category include:
The Genome Analysis Toolkit or GATK is a software package developed at the Broad Institute to analyze high-throughput sequencing data. The toolkit offers a variety of tools, with a primary focus on variant discovery and genotyping as well as strong emphasis on data quality assurance.
Looking at Genome Analysis Toolkit customers by industry, we find that Higher Education (29%), Hospital & Health Care (19%), Education Management (7%), Biotechnology (7%), Pharmaceuticals (7%) and Computer Software (5%) are the largest segments.
70% of Genome Analysis Toolkit customers are in United States and 6% are in United Kingdom.